Researchers have identified the JAK/STAT pathway as a key target for restoring immune response in RSV patients. The virus suppresses this pathway, inhibiting the activation of antiviral genes by interferon-alpha. Inhibiting this process allows the virus to evade the immune system and cause serious medical issues. Understanding this mechanism could lead to new therapies to treat RSV and potentially clear infections in vulnerable populations. Recent efforts to develop RSV vaccines and the implementation of vaccination programs aim to reduce hospitalizations and ICU admissions related to the virus. This research provides valuable insights for drug designers to develop effective treatments for RSV.
Source link
Irish scientists pinpoint new drug target for RSV
